Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-1449-2016

Drug recall · August 3, 2016

Divalproex Sodium Delayed-release Tablets USP recall

Why: Failed Tablet/Capsule Specifications

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01.

Lots / codes

Lot #: 02D163, Exp. 9/2017

Quantity
14, 370 units
Company
Teva North America, Horsham, PA
Distribution
Nationwide and Puerto Rico
Initiated
May 18, 2016 · Voluntary: Firm initiated
Classified
July 27, 2016
Reported
August 3, 2016
Ended
January 17, 2017
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.